|
|
 |
|
In our cooperation with (corporate) Venture Capitalists and DSM Venturing, the
challenge is to develop good relationships, combine resources and to share
leads as well as technical and business know-how.
Cooperation with Venture Capitalists can be:
-
Investments in Venture Capital funds
-
Co-investments with Venture Capitalists
-
The sharing of dealflow
-
The combining of due diligence efforts
At the moment we work together with the following Venture Capital funds:
|
|
 | Accelerated Technologies - Hackensack, USA |
|
Funds: Accelerated Technologies II, L.P. (AT II)
Medical devices incubator focusing on cardiovascular and aging diseases
applications.
|
|
 | Ampersand Ventures - Boston, USA |
|
Funds: AMP 1995 and 1999
Specialty materials and chemicals, life sciences, IT and communication.
|
|
 | Burrill & Company - San Francisco, USA |
|
Funds: Nutraceuticals and Life Science Capital Funds
Entire spectrum of life sciences, including human healthcare biotechnology,
agricultural biotechnology, nutraceuticals, human healthcare diagnostics and
industrial biotechnology (biomaterials and bioprocesses).
|
|
 | Emerald Technology Ventures - Zürich, Switzerland |
|
Funds: ETV II
Innovative technologies in energy, materials and water.
|
|
 | Life Science Partners - Amsterdam, The Netherlands |
|
Fund: LSP II
Human life sciences.
|
|
 | Millenium Materials Technologies Funds - Tel Aviv, Israel |
|
Fund: MMT II
Advanced materials in the fields of nano-technology, polymer technologies,
bio-materials, energy & environmental technologies, industrial chemistry and
novel crystals.
|
|
 | NGEN - Santa Barbara, USA |
|
Fund: NGEN enabling technologies fund
Polymers and biomaterials, displays and electronic materials
technologies,computer simulation technologies, energy and
environment,telecommunications technologies.
|
|
 | Sherbrooke Capital - Newton Lower Falls, USA |
|
Fund: Health & Wellness II
Product, service and technology innovations in the emerging area of health and
wellness.
|
|
| |
